VERONA PHARMA PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 15.47 USD | +1.05% |
|
-1.59% | -22.18% |
Chart calendar Verona Pharma plc
be9552696624d6f2bff302.9X1QsvepCCIYJdL9nJDts2-dKxwAjkyAkC3i0avkNcc.kgQe17yaW1d6U4LQxP-l5AfMRl9huQDI6UWvmMOSGIOwHjKCwvljTHJwvQ~1452b921bad394345229730dd8c946e7
Upcoming events on Verona Pharma plc
Past events on Verona Pharma plc
| 29/02/2024 14:00 | Q4 2023 Earnings Call |
| 29/02/2024 07:00 | Q4 2023 Earnings Release |
| 11/01/2024 00:30 | JPMorgan Healthcare Conference |
| 29/11/2023 19:35 | Evercore ISI HealthCONx Conference |
| 28/11/2023 13:00 | Piper Sandler Healthcare Conference |
| 15/11/2023 15:00 | Jefferies London Healthcare Conference |
| 02/11/2023 13:00 | Q3 2023 Earnings Call |
| 02/11/2023 07:04 | Q3 2023 Earnings Release |
| 18/10/2023 13:00 | Business Update Call |
| 09/10/2023 22:00 | CHEST Meeting |
| 09/08/2023 17:00 | Canaccord Genuity Growth Conference |
| 03/08/2023 14:00 | Q2 2023 Earnings Call |
| 03/08/2023 07:00 | Q2 2023 Earnings Release |
| 07/06/2023 13:00 | Jefferies Global Healthcare Conference |
| 23/05/2023 21:00 | American Thoracic Society International Conference |
| 18/05/2023 | American Thoracic Society International Conference - Abstract No - P176 |
| 18/05/2023 | American Thoracic Society International Conference - Abstract No - P175 |
| 18/05/2023 | American Thoracic Society International Conference - Abstract No - P174 |
| 18/05/2023 | American Thoracic Society International Conference - Abstract No - P173 |
| 18/05/2023 | American Thoracic Society International Conference - Abstract No - P172 |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million GBP | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 30,0 24,6 21.63% | 0,38 6,87 -94.46% | 0,00 0,00 - | 15,3 |
|
EBITDA Million GBP | Released Forecast Spread | -40,6 -35,1 -15.94% | -52,1 -40,9 -27.36% | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million GBP | Released Forecast Spread | -41,1 -46,4 11.38% | -52,7 -49,1 -7.28% | -54,9 -64,1 14.25% | -63,0 -56,6 -11.29% | -53,4 -55,7 4.11% | -87,8 |
|
Earnings before Tax (EBT) Million GBP | Released Forecast Spread | -39,2 -43,4 9.76% | -46,1 -49,4 6.55% | -41,6 -54,2 23.15% | -56,9 -53,8 -5.73% | -42,6 -48,5 12.12% | -83,4 |
|
Net income Million GBP | Released Forecast Spread | -31,9 -36,5 12.41% | -46,2 -44,8 -3.21% | -41,6 -52,3 20.42% | -57,1 -53,5 -6.82% | -43,0 -49,1 12.54% | -83,5 |
|
EPS USD | Released Forecast Spread | -3,13 -3,43 8.59% | -2,00 -2,03 1.57% | -0,96 -0,88 -8.88% | -1,04 -0,65 -59.18% | -0,09 -0,47 80.97% | -0,64 |
| Announcement Date | 27/02/20 | 25/02/21 | 03/03/22 | 07/03/23 | 29/02/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million GBP | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 2,95 - | 0,38 3,44 -88.92% | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,22 | 5,77 | 9,35 | 14,7 |
|
EBIT Million GBP | Released Forecast Spread | -21,3 -26,0 17.99% | -20,0 -22,7 11.65% | -16,9 -21,2 20.01% | -13,1 -15,3 14.72% | -12,5 -9,92 -26.12% | -17,6 -13,6 -29.7% | -7,84 -17,9 56.22% | -13,5 -18,4 26.83% | -15,1 -15,8 4.73% | -17,4 | -22,1 | -23,9 | -24,5 | -19,8 |
|
Earnings before Tax (EBT) Million GBP | Released Forecast Spread | -17,6 -24,2 27.35% | -19,8 -21,1 6.29% | -14,6 -19,0 23.1% | -13,5 -13,4 -0.78% | -8,66 -9,14 5.18% | -13,1 -13,0 -0.97% | -6,69 -17,5 61.72% | -12,1 -17,2 29.93% | -11,2 -15,9 29.43% | -16,1 | -20,8 | -22,8 | -23,6 | -18,0 |
|
Net income Million GBP | Released Forecast Spread | -17,4 -23,6 26.11% | -19,9 -21,3 6.61% | -14,7 -18,7 21.72% | -13,5 -13,1 -2.98% | -8,69 -8,87 2.1% | -13,3 -13,3 0.02% | -6,93 -17,8 61.06% | -12,1 -17,5 30.74% | -11,2 -16,0 30.16% | -16,2 | -20,8 | -22,8 | -23,6 | -18,0 |
|
EPS USD | Released Forecast Spread | -0,40 -0,35 -15.61% | -0,40 -0,29 -37.93% | -0,32 -0,27 -20% | -0,03 -0,13 76.4% | -0,16 -0,08 -104.26% | -0,24 -0,11 -118.18% | -0,08 -0,21 61.29% | -0,16 -0,03 -392.31% | -0,02 -0,16 87.16% | -0,13 | -0,16 | -0,19 | -0,17 | -0,03 |
| Announcement Date | 03/03/22 | 03/05/22 | 09/08/22 | 09/11/22 | 07/03/23 | 09/05/23 | 03/08/23 | 02/11/23 | 29/02/24 | - | - | - | - | - |
More events
Past sector events for Verona Pharma plc
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- VRNA Stock
- Calendar Verona Pharma plc
